Prevalence and clinical profile and management of peripheral arterial disease in elderly patients with diabetes

European Journal of Internal Medicine

Volumn 22, Issue 3, 2011, Pages 275-281

  Escobar, Carlos ^a   Blanes, Ignacio ^b   Ruiz, Andres ^c   Vinuesa, David ^c   Montero, Manuel ^d   Rodríguez, Melchor ^e   Barbera, Gloria ^f   Manzano, Luis ^g  

^a HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^b HOSPITAL DE MANISES   (Spain)

^c HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^e HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^f Departamento de Economía de la Salud   (Spain)

^g UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Diabetes; Elderly; Peripheral arterial disease

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BIGUANIDE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EZETIMIBE; FIBRIC ACID DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PENTOXIFYLLINE; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL;

AGE DISTRIBUTION; AGED; AGING; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART DISEASE; HUMAN; HYPERTENSION; LEG AMPUTATION; LEG ISCHEMIA; LEG REVASCULARIZATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT CARE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL ACTIVITY; PREVALENCE; RISK FACTOR; SEDENTARY LIFESTYLE; SMOKING; SURGEON; VASCULAR SURGERY;

AGE DISTRIBUTION; AGED; AMPUTATION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; ISCHEMIA; LOGISTIC MODELS; MALE; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; RISK FACTORS; SPAIN; VASCULAR SURGICAL PROCEDURES;

EID: 79955988321     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.02.001     Document Type: Article

References (35)

1. Stehouwer CD, Clement D, Davidson C, Diehm C, Elte JW, Lambert M, et al. Peripheral arterial disease: a growing problem for the internist. Eur J Intern Med 2009;20:132-8.
2. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-24. (Pubitemid 33015522)
3. Hackam DG, Tan MK, Lin PJ, Mehta PG, Jaffer S, Kates M, et al. Supporting a call to action for peripheral artery disease: insights from two prospective clinical registries. J Vasc Surg 2006;44:776-81. (Pubitemid 44444934)
4. Brevetti G, Schiano V, Verdoliva S, Silvestro A, Sirico G, De Maio J, et al. Peripheral arterial disease and cardiovascular risk in Italy. Results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study. J Cardiovasc Med (Hagerstown) 2006;7:608-13. (Pubitemid 44350496)
5. Ouriel K. Peripheral arterial disease. Lancet 2001;358:1257-64. (Pubitemid 33010855)
6. Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S, et al. High prevalence of peripheral arterial disease and comorbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004;172:95-105. (Pubitemid 38058606)
7. American Diabetes Association. Position statement: standards of medical care in diabetes. Diab Care 2009;32:S13-61.
8. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999;48:937-42. (Pubitemid 29226337)
9. Murabito JM, D'Agostino RB, Silbershatz H, Wilson WF. Intermittent claudication: a risk profile from the Framingham Heart Study. Circulation 1997;96:44-9. (Pubitemid 27298402)
10. American Diabetes Association. Peripheral arterial disease in people with diabetes. American Diabetes Association. Diab Care 2003;26:3333-41.
11. Manzano L, García-Díaz J, de D, Gómez-Cerezo J, Mateos J, del Valle FJ, et al. Clinical value of the ankle-brachial index in patients at risk of cardiovascular disease but without known atherothrombotic disease: VITAMIN study. Rev Esp Cardiol 2006;59:662-70. (Pubitemid 44349815)
12. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992;45:1101-9.
13. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-47.
14. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001;344:1608-21. (Pubitemid 32479915)
15. Neri Serneri GG, Coccheri S, Marubini E, Violi F. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study. Eur Heart J 2004;25:1845-52. (Pubitemid 39330236)
16. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87. (Pubitemid 46924065)
17. National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106 3143-21.
18. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003;163:884-92. (Pubitemid 36519734)
19. Bertomeu V, Morillas P, Gonzalez-Juanatey JR, Quiles J, Guindo J, Soria F, et al. Prevalence and prognostic influence of peripheral arterial disease in patients > or = 40 years old admitted into hospital following an acute coronary event. Eur J Vasc Endovasc Surg 2008;36:189-96. (Pubitemid 351965492)
20. Cacoub P, Cambou JP, Kownator S, Belliard JP, Beregi JP, Branchereau A, et al. Prevalence of peripheral arterial disease in high-risk patients using ankle-brachial index in general practice: a cross-sectional study. Int J Clin Pract 2009;63:63-70.
21. Vlek A, Visseren F, Algra A, Soedamah-Muthu S, Moll F, Doevendans P, et al. Trends in vascular risk factors and medication use in patients with various manifestations of vascular diseases or type 2 diabetes mellitus from 1996 to 2007: the Second Manifestations of ARTerial disease study. Eur J Cardiovasc Prev Rehabil 2011;17:628-36.
22. Bansal S, Wackers FJ, Inzucchi SE, Chyun DA, Davey JA, Staib LH, et al. Five-year outcomes in "high-risk" participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study. A post-hoc analysis. Diabetes Care 2011;34:204-9.
23. Lange S, Diehm C, Darius H, Haberl R, Allenberg JR, Pittrow D, et al. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes. Exp Clin Endocrinol Diabetes 2004;112:566-73. (Pubitemid 39664695)
24. Ogren M, Hedblad B, Engstrom G, Janzon L. Prevalence and prognostic significance of asymptomatic peripheral arterial disease in 68-year-old men with diabetes. Results from the Population Study "Men Born in 1914" from Malmo, Sweden. Eur J Vasc Endovasc Surg 2005;29:182-9.
25. Elhadd TA, Robb R, Jung RT, Stonebridge PA, Belch JJF. Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic. Pract Diab Int 1999;16:163-6. (Pubitemid 29467173)
26. Manzano L, Mostaza JM, Suarez C, Del Valle FJ, Ortiz JA, Sampedro JL, et al. Prognostic value of the ankle-brachial index in elderly patients with a stable chronic cardiovascular event. J Thromb Haemost 2010;8:1176-84.
27. Shammas N. Epidemiology, classification and modificable risk factors of peripheral arterial disease. Vasc Health Risk Manage 2007;3:229-34. (Pubitemid 46860711)
28. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter Society Consensus for the management of peripheral arterial disease. Eur J Vasc Endovasc Surg 2007;33:S1-S75. (Pubitemid 46068992)
29. Flu HC, Tamsma JT, Lindeman JH, Hamming JF, Lardenoye JH. A systematic review of implementation of established recommended secondary prevention measures in patients with PAOD. Eur J Vasc Endovasc Surg 2010;39:70-86.
30. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensinconverting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.
31. Barrios V, Escobar C, Prieto L, Herranz I. Adverse events in clinical trials: is a new approach needed? Lancet 2008;372:535-6.
32. Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA 2009;301:1909-19.
33. Basili S, Raparelli V, Vestri A, Di Tanna GL, Violi F. Comparison of efficacy of antiplatelet treatments for patients with claudication. A meta-analysis. Thromb Haemost 2010;103:766-73.
34. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
35. Regensteiner JG, Ware Jr JE, McCarthy WJ, Zhang P, Forbes WP, Heckman J, et al. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc 2002;50:1939-46. (Pubitemid 35462438)